Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 14/20 | 0.58 |
| ▸ | PPARA | Q07869 | 13/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 12/20 | 0.58 |
| ▸ | PTGES | O14684 | 9/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | MMP9 | P14780 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5080497 | 0.89 | PPARG (0.72) | PPARGPPARAALOX5PTGESFOLH1 | |
| SCHEMBL5081085 | 0.88 | PPARG (0.66) | PPARGPPARAALOX5PTGESFOLH1 | |
| SCHEMBL15141791 | 0.87 | PPARG (0.47) | PPARGPPARAALOX5PTGESHTT | |
| SCHEMBL8356987 | 0.86 | PPARG (0.64) | PPARGPPARAALOX5PTGESFOLH1 | |
| SCHEMBL22612343 | 0.86 | PPARG (0.64) | PPARGPPARAALOX5PTGESFOLH1 | |
| SCHEMBL9099036 | 0.86 | PPARG (0.64) | PPARGPPARAALOX5PTGESFOLH1 | |
| SCHEMBL9099026 | 0.86 | PPARG (0.64) | PPARGPPARAALOX5PTGESFOLH1 | |
| SCHEMBL20886629 | 0.86 | PPARG (0.66) | PPARGPPARAALOX5PTGESHTT | |
| SCHEMBL1931269 | 0.85 | HTT (0.71) | PPARGPPARAALOX5PTGESHTT | |
| SCHEMBL9099120 | 0.85 | HTT (0.71) | PPARGPPARAALOX5PTGESHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030225074-A1 | Dihetero-substituted metalloprotease inhibitors | THE PROCTER & GAMBLE COMPANY | 2003-12-04 | — | — | US | claimed |
| CN-119875006-A | Method for preparing degradable polyacrylamide fracturing fluid through RAFT polymerization method | 河北工业大学 | 2025-04-25 | — | — | CN | disclosed |
| EP-1944656-B1 | TONER FOR DEVELOPING ELECTROSTATIC IMAGES, TONER KITS, AND IMAGE FORMATION EQUIPMENT | RICOH CO LTD (JP) | 2016-05-04 | — | — | EP | disclosed |
| US-8007976-B2 | Electrostatic image developing toner, toner kit and image forming apparatus | RICOH COMPANY. LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-20090123186-A1 | ELECTROSTATIC IMAGE DEVELOPING TONER, TONER KIT AND IMAGE FORMING APPARATUS | RICOH COMPANY, LTD. (JP) | 2009-05-14 | — | — | US | disclosed |
| US-7452960-B2 | Polyhydroxyalkanoate copolymer, resin composition, molded product, toner, image forming method and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2008-11-18 | — | — | US | disclosed |
| EP-1944656-A1 | TONER FOR DEVELOPING ELECTROSTATIC IMAGES, TONER KITS, AND IMAGE FORMATION EQUIPMENT | Ricoh Company, Ltd. (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-20060040196-A1 | New polyhydroxyalkanoate copolymer, resin composition, molded product, toner, image forming method and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2006-02-23 | — | — | US | disclosed |
| EP-1579276-A1 | NOVEL POLYHYDROXYALKANOATE HAVING AMIDE, SULFONIC ACID OR SULFONATE ESTER GROUP, CHARGE CONTROL AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004061529-A1 | NOVEL POLYHYDROXYALKANOATE HAVING AMIDE, SULFONIC ACID OR SULFONATE ESTER GROUP, CHARGE CONTROL AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004041905-A1 | NEW POLYHYDROXYALKANOATE COPOLYMER, RESIN COMPOSITION, MOLDED PRODUCT, TONER, IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2004-05-21 | — | — | WO | disclosed |
| WO-2004037889-A1 | POLYHYDROXYALKANOATE, PROCESS FOR PREPARING THE SAME, AND RESIN COMPOSITION CONTAINING THE POLYHYDROXYALKANOATE | CANON KABUSHIKI KAISHA (JP) | 2004-05-06 | — | — | WO | disclosed |
| US-5112966-A | Intermediates for carbapenicillins | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1992-05-12 | — | — | US | disclosed |
| US-5075435-A | Chemical intermediates for 1-methylcarbapenicillin | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1991-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225074-A1 | Dihetero-substituted metalloprotease inhibitors | ADAM9, ADAM17, ADAM8 | PPARG 2880/4885PPARA 2854/4885ALOX5 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.